Weekly Lannett Company, Inc. (NYSE:LCI) Ratings on Apr 16, 2018

April 16, 2018 - By Nellie Rakes

Big Money Sentiment decreased to 1.38 in 2017 Q4. It has change of 0.10, from 2017Q3’s 1.48. The ratio turned negative due to Lannett Company, Inc. positioning: 17 sold and 44 reduced. 35 funds bought holdings and 49 increased holdings. Investors holded 27.62 million in 2017Q3 but now own 36.87 million shares or 33.49% more.
Sg Americas Ltd Liability Com has invested 0.01% in Lannett Company, Inc. (NYSE:LCI). Advsr Asset holds 540 shs. The Colorado-based Pub Employees Retirement Association Of Colorado has invested 0% in Lannett Company, Inc. (NYSE:LCI). Pnc Fincl Services Group Inc invested in 0% or 1,356 shs. Wells Fargo And Mn reported 51,040 shs. Northwestern Mutual Wealth Mngmt Co holds 286 shs or 0% of its capital. 60,300 are held by Macquarie Grp Inc Limited. Goldman Sachs Gp invested in 197,100 shs. Bankshares Of Mellon invested in 0% or 370,520 shs. 22,162 are owned by Globeflex L P. Invesco Limited accumulated 774,216 shs. Louisiana State Employees Retirement Sys owns 13,000 shs for 0.01% of their capital. Prudential Finance Inc holds 0% in Lannett Company, Inc. (NYSE:LCI) or 49,358 shs. California Public Employees Retirement Systems owns 79,490 shs for 0% of their capital. Principal Financial Gru holds 0% or 225,490 shs in its capital.

Lannett Company, Inc. had 2 selling transactions and 0 insider purchases since December 13, 2017. This’s net activity of $255,620.

Lannett Company, Inc. (NYSE:LCI) Ratings Coverage

In total 4 analysts cover Lannett (NYSE:LCI). “Buy” rating has 2, “Sell” are 0, while 2 are “Hold”. 50% are bullish. 5 are the (NYSE:LCI)’s analyst reports since November 13, 2017 according to StockzIntelligence Inc. On Monday, November 13 BMO Capital Markets maintained Lannett Company, Inc. (NYSE:LCI) with “Market Perform” rating. On Wednesday, February 7 the stock has “Buy” rating by Roth Capital. On Thursday, February 8 BMO Capital Markets maintained Lannett Company, Inc. (NYSE:LCI) rating. BMO Capital Markets has “Market Perform” rating and $21 target. Listed here are Lannett Company, Inc. (NYSE:LCI) PTs and latest ratings.

07/02/2018 Broker: Roth Capital Rating: Buy New Target: $25.0 Maintain
08/02/2018 Broker: BMO Capital Markets Old Rating: Market Perform New Rating: Market Perform Old Target: $22 New Target: $21 Maintain
24/01/2018 Broker: Goldman Sachs Rating: Neutral New Target: $21 Initiates Coverage On
01/12/2017 Broker: Raymond James Rating: Buy
13/11/2017 Broker: BMO Capital Markets Rating: Market Perform Old Target: $20 New Target: $22 Maintain

LCI reached $16.9 on during the last trading session after $0.45 change.Lannett Company, Inc. has volume of 421,650 shares. Since April 16, 2017 LCI has declined 34.08% and is downtrending. The stock underperformed the S&P500 by 45.63%.

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States.The company has $639.56 million market cap. The firm offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages.The P/E ratio is 13.19. It also provides its products for various medical indications comprising glaucoma, cholesterol, muscle spasm, migraine, pain management, cardiovascular, antipsychosis, gastrointestinal, urinary, bronchospasms, respiratory, gallstone, congestive heart failure, thyroid deficiency, central nervous system, and gout.

Lannett Company, Inc. (NYSE:LCI) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.